Original filing (PDF)20250506121939NAL0020400994001

MARYLAND PHARMACIES, INC.

Name: MARYLAND PHARMACIES, INC. — MARYLAND PHARMACIES, INC. CASH BALANCE PLAN, Form 5500 (2024)
Creator: MARYLAND PHARMACIES, INC.

Form 5500-SF

FILING_RECEIVED

MARYLAND PHARMACIES, INC. CASH BALANCE PLAN

Defined-benefit pension plan

Active participants

Accounts w/ balance

—

Plan assets (EOY)

$1.6M

Net assets (EOY)

$1.6M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for MARYLAND PHARMACIES, INC..

Plan sponsor

Name

MARYLAND PHARMACIES, INC.

EIN

75-3006510

Address

10313 GEORGIA AVENUE, SUITE 101 · SILVER SPRING, MD · 20902

Phone

(301) 681-5878

Industry

Wholesale Tradesee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

002

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-05-06

Pension benefit codes

1C · Cash balance or similar hybrid DB

3H · Sponsor in controlled / affiliated group

3D · Pre-approved plan (master / prototype / VS)

Audit & trust (Schedule H)

Auditor

—

Trustee / custodian

—

Trustee phone

—

Small plan (5500-SF) — Schedule H data not available.

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Wholesale Trade plans

BLESSINGS INTERNATIONAL

BLESSINGS INTERNATIONAL 403(B) RETIREMENT PLAN

$1.6M · 22 participants

UTAK LABORATORIES, INC.

UTAK LABORATORIES, INC. 401(K) RETIREMENT PLAN

$1.6M · 20 participants

ENDURANCE PRODUCTS COMPANY

ENDURANCE PRODUCTS COMPANY, INC. PROFIT SHARING PLAN

$1.6M · 10 participants

WELLSPRING PHARMACEUTICAL CORP

WELLSPRING PHARMACEUTICAL CORP 401(K) PROFIT SHARING PLAN & TRUST

$1.6M · 13 participants

ADVANCED MEDICAL SALES INC